Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients.
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);病例对照研究(Case-Control Studies);细胞色素P450 CYP1A1(Cytochrome P-450 CYP1A1);细胞色素P450 CYP2D6(Cytochrome P-450 CYP2D6);细胞色素P450 CYP2E1(Cytochrome P-450 CYP2E1);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);疾病遗传易感性(Genetic Predisposition to Disease);基因型(Genotype);谷胱甘肽转移酶(Glutathione Transferase);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);铂化合物(Platinum Compounds);多态现象, 遗传(Polymorphism, Genetic);比例危险度模型(Proportional Hazards Models);吸烟(Smoking);青年人(Young Adult)
DOI
10.1007/s00408-011-9338-8
PMID
22109568
发布时间
2022-03-11
- 浏览20

Lung
91-8页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文